Recent Publications

A complete listing of all publications are linked to PubMed here.

Alternatively, you can download a PDF copy here.

Most Recent Papers
  • Struwe, W.B.; Cosgrave, E.F.J.; Byrne, J.C.; Saldova, R.; Rudd, P.M. Glycoproteomics in Health and Disease. In: Functional and Structural Proteomics of Glycoproteins, Owens, R. J.; Nettleship, J. E. (Eds.), 1st Edition, 2011, X, pp. 1-38.
  • Telford, J. E.; Doherty, M. A.; Tharmalingam, T.; Rudd, P. M. Discovering new clinical markers in the field of glycomics. Biochem Soc Trans, 2011, 39(1), 327-330.
  • Cohen, M. et al. Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. PLoS One, 2011, 6(1), e14540.
  • Saldova, R., Fan, Y., Fitzpatrick, J. M., Watson, R. W., Rudd, P. M. Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology, 2011, 21(2), 195-205.
  • Shahrokh, Z., Royle, L. et al. Erythropoietin Produced in a Human Cell Line (Dynepo) Has Significant Differences in Glycosylation Compared with Erythropoietins Produced in CHO Cell Lines. Mol Pharm., 2011, 8 (1), 286–296.
  • von der Lieth, C. W.; Arda Freire, A. et al. EUROCarbDB: An open-access platform for glycoinformatics. Glycobiology, 2011, 21(4), 493–502.
  • Arnold, J. N.; Saldova, R. et al. Novel Glycan Biomarkers for the Detection of Lung Cancer. J Proteome Res., 2011, 10 (4), 1755–1764.
  • Bones, J.; Byrne, J. C. et al. Glycomic and Glycoproteomic Analysis of Serum from Patients with Stomach Cancer Reveals Potential Markers Arising from Host Defense Response Mechanisms. J Proteome Res., 2011, 10 (3), 1246–1265.
  • Saldova, R.; Fan, Y. et al. Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology, 2011, 21(2):195-205.
  • Artemenko, N.V.; Campbell, M.P.; Rudd, P.M.: GlycoExtractor: a web-based interface for high throughput processing of HPLC-glycan data. J Proteome Res., 2010, 9(4):2037-41.
  • Ahn, J.; Bones, J. et al. Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. J Chromatogr B, 2010, 878(3-4): 403-8.
  • Barrabes, S.; Sarrats, A. et al. Effect of sialic acid content on glycoprotein pI analyzed by two-dimensional electrophoresis. Electrophoresis, 2010, 31(17): 2903-2912.
  • Bones, J.; Mittermayr, S. et al. Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation. Anal Chem, 2010, 82(24): 10208-15.
  • Coman, D. J.; Murray, D. W. et al. Galactosemia, a single gene disorder with epigenetic consequences. Pediatr Res, 2010, 67(3): 286-92.
  • Ercan, A.; Cui, J. et al. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum, 2010, 62(8): 2239-48.
  • Harvey, D. J.; Jaeken, J. et al. Fragmentation of negative ions from N-linked carbohydrates, part 4. Fragmentation of complex glycans lacking substitution on the 6-antenna. J Mass Spectrom, 2010, 45(5): 528-35.
  • Harvey, D. J. and Rudd, P. M. Identification of by-products formed during the release of N-glycans with protein N-glycosidase F in the presence of dithiothreitol. J Mass Spectrom, 2010, 45(7): 815-9.
  • Knezevic, A., Gornik, O. et al. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology, 2010, 20(8): 959-69.
  • Lauc, G., Essafi, A. et al. Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet, 2010, 6(12): e1001256.
  • Lauc, G., Rudan, I. et al. Complex genetic regulation of protein glycosylation. Mol Biosyst, 2010, 6(2): 329-35.
  • Liu, L., Telford, J. E. et al. High-throughput glycoanalytical technology for systems glycobiology. Biochem Soc Trans, 2010, 38(5): 1374-7.
  • Marino, K., Bones, J. et al. A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol, 2010, 6(10): 713-23.
  • McVicar, C. M.; Colhoun, L. M. et al. Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy. PLoS One, 2010, 5(7): e11870-1 - e11870-16.
  • Montesino, R.; Gil, J. et al. The N-glycosylation of classical swine fever virus E2 glycoprotein extracellular domain expressed in the milk of goat. Arch Biochem Biophys, 2010, 500(2): 169-80.
  • Muindi, K.; Cernadas, M. et al. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d. Proc Natl Acad Sci U S A. 2010, 107(7):3052-7.
  • Peracaula, R.; Sarrats, A. et al. Liver proteins as sensor of human malignancies and inflammation. Proteomics Clin Appl, 2010, 4(4): 426-31.
  • Pierce, A.; Saldova, R. et al. Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients. Glycobiology, 2010, 20(10): 1283-8.
  • Pucic, M.; Pinto, S. et al. Common aberrations from the normal human plasma N-glycan profile. Glycobiology, 2010, 20(8): 970-5.
  • Ritchie, G.; Harvey, D.J. et al. Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein. Virology. 2010 Apr 10;399(2):257-69.
  • Ritchie, G.; Harvey, D.J. et al. Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom. 2010, 24(5):571-85.
  • Saldova, R., Fan, Y. et al. Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology, 2010, 21(2): 195-205.
  • Saldova, R.; Reuben, J. M. et al. Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts. Ann Oncol, 2010, mdq570
  • Sarrats, A.; Saldova, R. et al. Glycan Characterization of PSA 2-DE Subforms from Serum and Seminal Plasma. OMICS, 2010, 14(4): 465-74.